The most-read stories on Healio.com/OSN in December included an FDA approval and news from recent journal articles.
Here are the month’s top five ophthalmology stories:
1. Aerie Pharmaceuticals announces FDA approval of Rhopressa
Rhopressa (netarsudil ophthalmic solution 0.02%) is a once-daily eye drop designed to lower IOP in patients with open-angle glaucoma or ocular hypertension. Read more.
2. NovaTears+Omega-3 for evaporative dry eye approved in Europe
The first eye drop to have high concentrations of omega-3 (0.2%) ethyl ester of plant origin, NovaTears+Omega-3 stabilizes
Uncategorized